A 10‐year analysis of cutaneous mesenchymal tumors (sarcomas and related entities) in a skin cancer center

Abstract

Mesenchymal neoplasms (sarcomas) are an important group of cutaneous malignancies. Awareness needs to be improved.

Atypical fibroxanthoma management: Recurrence, metastasis and disease‐specific death

“…There were few recurrences reported and time to recurrence was poorly reported. Most cases of recurrence were within 24 months . Time to metastasis was also poorly reported by studies.…”

“…Local excision was the most common employed method of AFX treatment; MMS the second most common method. Radiotherapy was the most frequent adjuvant therapy employed …”

“…Deaths directly related to metastatic AFX are extremely rare. There have been 15 reported disease‐related deaths in the literature, compared to 52 cases of reported metastases. In the elderly patient populations death due to cause other than AFX was common.…”

“…A number of the studies had recurrences and metastases occurring in the same patients. Similarly, a number of studies repeated data from previous series . Attempts were made to eliminate duplicate cases but this was only possible where reported.…”

Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated

“…Nevertheless, occasional metastatic AFX have been reported . Some of these cases exhibited infiltration beyond the superficial subcutis or necrosis or lacked a complete histopathological description or immunohistochemical study.…”